Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0000899243-21-026769

Director bought 157,895 shares at $19.00 ($3,000,005)

  • Director acquired 8,455,912 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2021-06-28 Conversion +6,515,869 6,799,115 I
Bolzon Bradley J PhD Director 2021-06-28 Conversion +1,940,043 1,940,043 I
Bolzon Bradley J PhD Director 2021-06-28 Purchase +157,895 $19.00 $3,000,005 2,097,938 I
Derivatives
Bolzon Bradley J PhD Director 2021-06-28 Conversion · Series A convertible preferred stock −20,004,280 0 I
Bolzon Bradley J PhD Director 2021-06-28 Conversion · Series B convertible preferred stock −3,000,000 0 I
Bolzon Bradley J PhD Director 2021-06-28 Conversion · Series B convertible preferred stock −4,150,000 0 I
Bolzon Bradley J PhD Director 2021-06-28 Conversion · Series C convertible preferred stock −2,699,328 0 I
Open-market purchases · 157,895 sh · avg $19.00 · $3,000,005
Loading xslF345X03/doc4.xml…